Predictors | Male | Female | ||||
---|---|---|---|---|---|---|
HRa | 95%CI | P-value | HRa | 95%CI | P-value | |
Socio-demographics | ||||||
Age, years | 1.06 | (1.05,1.08) | <0.001* | 1.03 | (1.02,1.05) | <0.001* |
Smoker (Non-smoker) | 1.29 | (1.11,1.50) | 0.001* | |||
Disease characteristics | ||||||
Duration of T2DM, years | 1.01 | (1.00,1.02) | 0.046* | |||
STDR (No) | 1.47 | (1.18,1.84) | 0.001* | |||
Treatment modalities | ||||||
Anti-hypertensive drugs used (No) | 1.54 | (1.21,1.97) | 0.001* | 1.66 | (1.21,2.26) | 0.002* |
Oral drug (No) | 1.37 | (1.07,1.75) | 0.011* | 1.98 | (1.43,2.75) | <0.001* |
Insulin drug (No) | 9.79 | (1.66,57.62) | 0.012* | 1.73 | (1.30,2.29) | <0.001* |
Clinical parameters | ||||||
BMI, kg/m2 | 0.85 | (0.77,0.95) | 0.002* | |||
BMI2, kg/m2 | 1.003 | (1.001,1.005) | 0.001* | |||
HbA1c, % | 0.79 | (0.64,0.98) | 0.036* | 0.70 | (0.49,0.99) | 0.046* |
HbA1c2, % | 1.02 | (1.01,1.03) | 0.002* | 1.03 | (1.01,1.05) | 0.013* |
SBP, mmHg | 1.01 | (1.01,1.02) | <0.001* | 1.01 | (1.00,1.01) | 0.025* |
DBP, mmHg | 0.93 | (0.88,0.98) | 0.009* | 0.92 | (0.86,0.98) | 0.007* |
DBP2, mmHg | 1.0004 | (1.0000,1.0008) | 0.039* | 1.001 | (1.000,1.001) | 0.017* |
ln(Urine ACR + 1), mg/mmol | 3.15 | (2.11,4.69) | <0.001* | 1.45 | (1.37,1.53) | <0.001* |
eGFR (>90 ml/min/1.73m2) | ||||||
60-89 ml/min/1.73m2 | 2.45 | (2.08,2.88) | <0.001* | 2.00 | (0.38,10.51) | 0.412 |
< 60 ml/min/1.73m2 | 8.76 | (7.08,10.84) | <0.001* | 112.06 | (23.97,523.76) | <0.001* |
Age interaction term | ||||||
Age*eGFR(>90 ml/min/1.73m2) | ||||||
60-89 ml/min/1.73m2 | 1.003 | (0.979,1.028) | 0.816 | |||
< 60 ml/min/1.73m2 | 0.97 | (0.95,0.99) | 0.006* | |||
Age*insulin | 0.97 | (0.95,1.00) | 0.028* | |||
Age* ln(Urine ACR + 1) | 0.99 | (0.98,0.99) | <0.001* |